Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
1032784

Pharmaceutical Quality Management Software Market - A Global and Regional Analysis: Focus on Deployment Models, Applications, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030
Published: | BIS Research Inc. | 205 Pages | Delivery time: 1-2 business days

Price

Back to Top
Pharmaceutical Quality Management Software Market - A Global and Regional Analysis: Focus on Deployment Models, Applications, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030
Published: October 11, 2021
BIS Research Inc.
Content info: 205 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

“Global Pharmaceutical Quality Management Software Market to Reach $3,717.7 Million by 2030.”

Market Report Coverage - Pharmaceutical Quality Management Software

Market Segmentation

  • Application - Corrective Action Preventive Action (CAPA) Management, Audit Management, Document Management, Change Management, Training Management, Risk Management, Complaints Management, Regulatory and Compliance Management, Non-Conformances Handling, Supplier Quality Management, Inspection Management, Equipment Management, and Others.
  • Deployment Model - On-Cloud, Web-Based, and On-Premises
  • End User - Pharmaceutical, Life Sciences, and Biotechnology Companies, Contract Research Organizations, and Others

Regional Segmentation

  • North America - U.S. and Canada
  • Europe - Germany, U.K., France, Spain, Italy, and Rest-of-Europe
  • Asia-Pacific - Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
  • Rest-of-the-World - Brazil, Mexico, and Rest of Rest-of-the-World

Market Growth Drivers

  • Increasing Cost of Drugs Manufacturing
  • Constantly Evolving Regulations
  • Growing Technology Adoption in Pharmaceutical Industry

Market Challenges

  • Security Concerns Pertaining to On-Cloud Deployment
  • Lack of Regulations for Pharmaceutical Quality Management Software

Market Opportunities

  • Synergies Between Pharmaceutical Quality Management Software Developers and Local End User
  • Development of Solutions Based on Platform-as-a-Service Business Model

Key Companies Profiled

ANTARES VISION S.p.A, AssurX, Inc., AXSource, CLARIVATE PLC., ComplianceQuest, Dassault Systemes, EtQ Management Consultants, Inc., Honeywell International Inc., Ideagen Plc., IQVIA HOLDINGS INC., LogicGate, Inc, MasterControl, PTC Inc., Sarjen Systems Pvt. Ltd., Qualio, Veeva Systems Inc.

How This Report Can Add Value

Assuming that the reader is a developer of pharmaceutical quality management software, they will be able to do the following:

  • Understand their position as compared to some of the key players in the market
  • Stay updated with novel technology integration, features, and the latest developments in the market
  • Understand the impact of COVID-19 on the adoption of pharmaceutical QMS and the entry barriers as a result of it
  • Gain insights into which regions to target globally based on factors such as the technology adoption in the pharmaceutical industry and government established regulations
  • To gain insights into end-user perception with respect to the adoption of pharmaceutical QMS systems
  • Identify some of the key players in the market and understand their valuable contribution

Key Questions Answered in the Global Pharmaceutical Quality Management Market Report:

  • How did the COVID-19 pandemic impact the adoption of pharmaceutical quality management software by various pharmaceutical and life sciences companies?
  • What is the outlook for the global pharmaceutical quality management software market during the forecast period 2021-2030?
  • What are the key trends influencing the global pharmaceutical quality management software market? How will they influence the market in short-, mid-, and long-term duration?
  • What is the end user perception toward pharmaceutical quality management software?
  • How is the patent landscape for pharmaceutical quality software? Which country/cluster witnessed the highest patent filing from January 2014-June 2021?
  • What are the key factors impacting the global pharmaceutical quality management software market? What will be their impact in short-, mid-, and long-term duration?
  • What are the key opportunities areas in the global pharmaceutical quality management software market? What is their potential in short-, mid-, and long-term duration?
  • What are the key strategies adopted by companies in the global pharmaceutical quality management software market?
  • What are the key application areas of the global pharmaceutical quality management software market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030?
  • What is the preferred deployment model for the global pharmaceutical quality management software? What is the growth potential of various deployment models present in the market?
  • Who are the key end users of pharmaceutical quality software? What is their respective share in the global pharmaceutical quality management software market?
  • Which regional market is expected to hold the highest growth potential in the global pharmaceutical quality management software market during the forecast period 2021-2030?
  • Which are the key players in the global pharmaceutical quality management software market?

Global Pharmaceutical Quality Management Software Market Industry Overview

The manufacture of drugs and pharmaceutical products passes through various processing steps, each of which requires monitoring to ensure the safety, efficacy, and quality of the manufactured product. Traditional paper-based quality management systems are associated with various drawbacks that can be overcome by software-based quality management systems.

While the pharmaceutical quality management software market is still in its niche stage, the market is anticipated to grow rapidly owing to increasing technology adoption in the pharmaceutical industry, increasing cost of drug manufacturing, and evolving regulations. Currently, a few large pharmaceutical companies have adopted electronic quality management systems in order to automate their processes. With increasing technology adoption in the pharmaceutical industry, going forward, smaller companies are expected to implement software-based systems from the beginning itself.

The COVID-19 pandemic has further accelerated the digital transformation of the pharmaceutical industry. This positive impact is attributed to factors such as travel restrictions and the emerging concept of working and communicating remotely.

The global pharmaceutical quality management software market report highlights that the market was valued at $472.6 million in 2020 and is expected to reach $3,717.7 million by the end of 2030. The market is expected to grow at a CAGR of 22.91% during the forecast period from 2021 to 2030.

Global Pharmaceutical Quality Management Software Market Drivers

The factors driving the growth of the market include the increasing cost of drug manufacturing, constantly evolving regulations, and growing technology adoption in the pharmaceutical industry. Pharmaceutical companies spend up to billions of dollars in the manufacture of a new drug, thereby increasing the demand for automating manufacturing processes. The benefits associated with paper-based quality management systems are overcome by software-based quality management systems, presenting a lucrative market for pharmaceutical quality management software.

Furthermore, increasing demand by pharmaceutical companies to comply with regulatory requirements in order to compete with other players in the market is another factor driving the growth of the market.

Global Pharmaceutical Quality Management Software Market Challenges

The factors restraining the growth of the global pharmaceutical quality management software include security concerns pertaining to on-cloud deployment and the lack of well-established regulations governing pharmaceutical quality management software systems. Data breach incidents cause the pharmaceutical industry to suffer both monetary losses as well as breaches of customer trust. Additionally, while emerging economies in Asia-Pacific and Rest-of-the-World present a huge potential for growth of the pharmaceutical quality management software market, currently, market penetration in the region is challenging owing to factors such as lack of technology integration in the pharmaceutical industry and high upfront costs associated with the purchase of software.

However, the COVID-19 pandemic has countered these challenges and thus, positively impacted the digital transformation of the pharmaceutical industry.

Global Pharmaceutical Quality Management Software Market Opportunities

Synergies between pharmaceutical QMS developers and local end users and the development of solutions based on platform-as-a-service business model hold immense potential for the growth of the global pharmaceutical quality management software market.

The development of solutions based on the platform-as-a-service model is a novel model for running applications such as quality management software wherein a third party maintains the hardware and software infrastructure and delivers it to users over the internet. The software developers are adopting the PaaS solutions due to their simplicity, scalability, and reliability.

Impact of COVID-19 on the Global Pharmaceutical Quality Management Software Market

A paradigm shift in consumer preference from a paper-based management system to a digital cloud-based system has been witnessed in the past decade. The pandemic had a positive impact on the global pharmaceutical quality management software market. This is attributed to government-imposed restrictions during the lockdown and the shift towards working remotely. The realized benefits are expected to influence user perception post-COVID as well. Some of these benefits include:

  • Time saving due to systematic categorization and storage of documentation
  • Convenient approach to storage, manage and make sense of large amounts of data
  • Higher revenue stream, in the long run, owing to cost savings
  • Cost savings are realized in areas such as non-conformity and complaints
  • Streamlined workflow enabling more efficient communication and collaboration within the organization as well as with clients

Market Segmentation

Global Pharmaceutical Quality Management Software Market (by Deployment Model)

The global pharmaceutical quality management software market has been segmented on the basis of deployment model into three broad categories, namely, on-cloud, web-based, and on-premises.

The on-cloud deployment model offers significant benefits over the traditional on-premises software or paper-based system. With the cloud-based system, it is easier to upgrade to the electronic QMS. The model can be accessed remotely in a highly secured environment. The model is also easily scalable, which allows clients to add more users and storage according to the business needs in the future.

Global Pharmaceutical Quality Management Software Market (by Application)

The global pharmaceutical quality management software market has been segmented on the basis of application into corrective action preventive action (CAPA) management, audit management, document management, change management, training management, risk management, complaints management, regulatory and compliance management, non-conformances handling, supplier quality management, inspection management, equipment management, and others.

Rising technology adoption in the pharmaceutical industry and increasing demand to automate processes to ensure regulatory compliance are major factors driving the growth of various quality management application areas.

Global Pharmaceutical Quality Management Software Market (by End User)

The global pharmaceutical quality management software market has been segmented on the basis of end users into three categories, namely, pharmaceutical, life sciences companies, and biotechnology companies, contract research organizations, and others.

Pharmaceutical, life sciences, and biotechnology companies are the major end users of the global pharmaceutical quality management software market. The adoption of quality management software is increasing in these industries due to the rapid growth of industries and ease of use. With the adoption of pharmaceutical QMS systems, the industries can better control, manage compliance, and assess the products for quality.

Contract research organizations (CRO) are the emerging end-user segment of the global pharmaceutical quality management software market. The trend is driven by both pharmaceutical and biotechnology companies outsourcing certain processes to CROs.

Global Pharmaceutical Quality Management Software Market (by Region)

The different regions covered under the global urgent care apps market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America and Europe are two of the largest markets for pharmaceutical quality management software. This is attributed to increasing technology integration in the pharmaceutical industry. While developing countries such as those in Asia-Pacific and the Rest-of-the-World currently offer challenges to pharmaceutical QMS developers to enter the market in these regions, they are expected to register strong growth in the adoption of pharmaceutical quality management software in the near future.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include: ANTARES VISION S.p.A, AssurX, Inc., AXSource, CLARIVATE PLC., ComplianceQuest, Dassault Systemes, EtQ Management Consultants, Inc., Honeywell International Inc., Ideagen Plc., IQVIA HOLDINGS INC., LogicGate, Inc, MasterControl, PTC Inc., Sarjen Systems Pvt. Ltd., Qualio, and Veeva Systems Inc.

In the past few years, the global pharmaceutical quality management software market has witnessed several strategic and technological developments undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been partnerships followed by funding activities.

Product Code: BHD1119SA

Table of Contents

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Key Findings and Opportunity Assessment
      • 1.1.1.1 Key Findings
      • 1.1.1.2 Opportunity Assessment
    • 1.1.2 Growth Scenarios
      • 1.1.2.1 Realistic Growth Scenario
      • 1.1.2.2 Optimistic Growth Scenario
      • 1.1.2.3 Pessimistic/Conservative Growth Scenario
  • 1.2 Industry Analysis
    • 1.2.1 Key Trends
      • 1.2.1.1 Potential Analysis
        • 1.2.1.1.1 Short-Term Potential (2-4 Years)
        • 1.2.1.1.2 Mid-Term Potential (5-10 Years)
        • 1.2.1.1.3 Long-Term Potential (8-12 Years)
    • 1.2.2 Value Chain Analysis
    • 1.2.3 Readiness Index
    • 1.2.4 Technology Adoption Matrix
    • 1.2.5 Cost Benefit Analysis
    • 1.2.6 End User Perception
    • 1.2.7 Case Studies
      • 1.2.7.1 Case Study: Alphazyme and Qualio
      • 1.2.7.2 Case Study: AL Andalous and AmpleLogic
    • 1.2.8 Patent Analysis
      • 1.2.8.1 Patent Analysis, by Year
      • 1.2.8.2 Patent Analysis, by Country/Cluster
  • 1.3 Impact of COVID-19 on Global Pharmaceutical Quality Management Software Market
    • 1.3.1 Impact on Adoption of Pharmaceutical Quality Management Software
    • 1.3.2 Impact on Market Size
      • 1.3.2.1 Scenario Comparison Analysis
    • 1.3.3 Future Outlook and Recommendations
  • 1.4 Market Dynamics
    • 1.4.1 Market Drivers
      • 1.4.1.1 Increasing Cost of Drugs Manufacturing
      • 1.4.1.2 Constantly Evolving Regulations
      • 1.4.1.3 Growing Technology Adoption in Pharmaceutical Industry
    • 1.4.2 Market Restraints
      • 1.4.2.1 Security Concerns Pertaining to On-Cloud Deployment
      • 1.4.2.2 Lack of Regulations for Pharmaceutical Quality Management Software
    • 1.4.3 Impact Analysis
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Synergies Between Pharmaceutical Quality Management Software Developers and Local End User
      • 1.4.4.2 Development of Solutions Based on Platform-as-a-Service Business Model
      • 1.4.4.3 Opportunities Analysis (Short-, Mid-, and Long-Term Duration)
        • 1.4.4.3.1 Short-Term Impact
        • 1.4.4.3.2 Mid-Term Impact
        • 1.4.4.3.3 Long-Term Impact
    • 1.4.5 Business Model Analysis

2 Application

  • 2.1 Global Pharmaceutical Quality Management Software Market (by Application)
    • 2.1.1 Opportunity Assessment
    • 2.1.2 Growth-Share Matrix
    • 2.1.3 Corrective Action Preventive Action (CAPA) Management
    • 2.1.4 Audit Management
    • 2.1.5 Document Management
    • 2.1.6 Change Management
    • 2.1.7 Training Management
    • 2.1.8 Risk Management
    • 2.1.9 Complaints Management
    • 2.1.10 Regulatory and Compliance Management
    • 2.1.11 Non-Conformances Handling
    • 2.1.12 Supplier Quality Management
    • 2.1.13 Inspection Management
    • 2.1.14 Equipment Management
    • 2.1.15 Others
  • 2.2 Global Pharmaceutical Quality Management Software Market (by End User)
    • 2.2.1 Opportunity Assessment
    • 2.2.2 Pharmaceutical, Life Sciences, and Biotechnology Companies
    • 2.2.3 Contract Research Organizations
    • 2.2.4 Others

3 Product

  • 3.1 Global Pharmaceutical Quality Management Software Market (by Deployment Model)
    • 3.1.1 Opportunity Assessment
    • 3.1.2 Growth-Share Matrix
    • 3.1.3 On-Cloud
    • 3.1.4 Web-Based
    • 3.1.5 On-Premises

4 Region

  • 4.1 North America
    • 4.1.1 Market
      • 4.1.1.1 Key Findings and Opportunity Assessment
      • 4.1.1.2 Market Dynamics: Impact Analysis
      • 4.1.1.3 Regulations in North America
      • 4.1.1.4 Market Size and Forecast
    • 4.1.2 Application
      • 4.1.2.1 North America Pharmaceutical Quality Management Software Market (by End User)
    • 4.1.3 Product
      • 4.1.3.1 North America Pharmaceutical Quality Management Software Market (by Deployment Model)
    • 4.1.4 North America (by Country)
      • 4.1.4.1 U.S.
        • 4.1.4.1.1 Market
          • 4.1.4.1.1.1 Buyer Attributes
          • 4.1.4.1.1.2 Market Drivers
          • 4.1.4.1.1.3 Market Restraints
      • 4.1.4.2 Canada
        • 4.1.4.2.1 Market
          • 4.1.4.2.1.1 Buyer Attributes
          • 4.1.4.2.1.2 Market Drivers
          • 4.1.4.2.1.3 Market Restraints
  • 4.2 Europe
    • 4.2.1 Market
      • 4.2.1.1 Key Findings and Opportunity Assessment
      • 4.2.1.2 Market Dynamics: Impact Analysis
      • 4.2.1.3 Regulations in Europe
      • 4.2.1.4 Market Size and Forecast
    • 4.2.2 Application
      • 4.2.2.1 Europe Pharmaceutical Quality Management Software Market (by End User)
    • 4.2.3 Product
      • 4.2.3.1 Europe Pharmaceutical Quality Management Software Market (by Deployment Model)
    • 4.2.4 Europe (by Country)
      • 4.2.4.1 Germany
        • 4.2.4.1.1 Market
          • 4.2.4.1.1.1 Buyer Attributes
          • 4.2.4.1.1.2 Market Drivers
          • 4.2.4.1.1.3 Market Restraints
      • 4.2.4.2 U.K.
        • 4.2.4.2.1 Market
          • 4.2.4.2.1.1 Buyer Attributes
          • 4.2.4.2.1.2 Market Drivers
          • 4.2.4.2.1.3 Market Restraints
      • 4.2.4.3 France
        • 4.2.4.3.1 Market
          • 4.2.4.3.1.1 Buyer Attributes
          • 4.2.4.3.1.2 Market Drivers
          • 4.2.4.3.1.3 Market Restraints
      • 4.2.4.4 Italy
        • 4.2.4.4.1 Market
          • 4.2.4.4.1.1 Buyer Attributes
          • 4.2.4.4.1.2 Market Drivers
          • 4.2.4.4.1.3 Market Restraints
      • 4.2.4.5 Spain
        • 4.2.4.5.1 Market
          • 4.2.4.5.1.1 Buyer Attributes
          • 4.2.4.5.1.2 Market Drivers
          • 4.2.4.5.1.3 Market Restraints
      • 4.2.4.6 Rest-of-Europe
        • 4.2.4.6.1 Market
          • 4.2.4.6.1.1 Buyer Attributes
          • 4.2.4.6.1.2 Market Drivers
          • 4.2.4.6.1.3 Market Restraints
  • 4.3 Asia-Pacific
    • 4.3.1 Market
      • 4.3.1.1 Key Findings and Opportunity Assessment
      • 4.3.1.2 Market Dynamics: Impact Analysis
      • 4.3.1.3 Regulations in Asia-Pacific
      • 4.3.1.4 Market Size and Forecast
    • 4.3.2 Application
      • 4.3.2.1 Asia-Pacific Pharmaceutical Quality Management Software Market (by End User)
    • 4.3.3 Product
      • 4.3.3.1 Asia-Pacific Pharmaceutical Quality Management Software Market (by Deployment Model)
    • 4.3.4 Asia-Pacific (by Country)
      • 4.3.4.1 Japan
        • 4.3.4.1.1 Market
          • 4.3.4.1.1.1 Buyer Attributes
          • 4.3.4.1.1.2 Market Drivers
          • 4.3.4.1.1.3 Market Restraints
      • 4.3.4.2 China
        • 4.3.4.2.1 Market
          • 4.3.4.2.1.1 Buyer Attributes
          • 4.3.4.2.1.2 Market Drivers
          • 4.3.4.2.1.3 Market Restraints
      • 4.3.4.3 South Korea
        • 4.3.4.3.1 Market
          • 4.3.4.3.1.1 Buyer Attributes
          • 4.3.4.3.1.2 Market Drivers
          • 4.3.4.3.1.3 Market Restraints
      • 4.3.4.4 India
        • 4.3.4.4.1 Market
          • 4.3.4.4.1.1 Buyer Attributes
          • 4.3.4.4.1.2 Market Drivers
          • 4.3.4.4.1.3 Market Restraints
      • 4.3.4.5 Australia and New Zealand
        • 4.3.4.5.1 Market
          • 4.3.4.5.1.1 Buyer Attributes
          • 4.3.4.5.1.2 Market Drivers
          • 4.3.4.5.1.3 Market Restraints
      • 4.3.4.6 Rest-of-Asia-Pacific
        • 4.3.4.6.1 Market
          • 4.3.4.6.1.1 Buyer Attributes
          • 4.3.4.6.1.2 Market Drivers
          • 4.3.4.6.1.3 Market Restraints
  • 4.4 Rest-of-the-World
    • 4.4.1 Market
      • 4.4.1.1 Key Findings and Opportunity Assessment
      • 4.4.1.2 Market Dynamics: Impact Analysis
      • 4.4.1.3 Regulations in Rest-of-the-World
      • 4.4.1.4 Market Size and Forecast
    • 4.4.2 Application
      • 4.4.2.1 Rest-of-the-World Pharmaceutical Quality Management Software Market (by End User)
    • 4.4.3 Product
      • 4.4.3.1 Rest-of-the-World Pharmaceutical Quality Management Software Market (by Deployment Model)
    • 4.4.4 Rest-of-the-World (by Country)
      • 4.4.4.1 Brazil
        • 4.4.4.1.1 Market
          • 4.4.4.1.1.1 Buyer Attributes
          • 4.4.4.1.1.2 Market Drivers
          • 4.4.4.1.1.3 Market Restraints
      • 4.4.4.2 Mexico
        • 4.4.4.2.1 Market
          • 4.4.4.2.1.1 Buyer Attributes
          • 4.4.4.2.1.2 Market Drivers`
          • 4.4.4.2.1.3 Market Restraints
      • 4.4.4.3 Rest of Rest-of-the-World
        • 4.4.4.3.1 Market
          • 4.4.4.3.1.1 Buyer Attributes
          • 4.4.4.3.1.2 Market Drivers
          • 4.4.4.3.1.3 Market Restraints

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Competitive Benchmarking
  • 5.2 Key Strategies
    • 5.2.1 Partnerships, Alliances, and Business Expansion
    • 5.2.2 New Offerings
    • 5.2.3 Funding Activities
    • 5.2.4 Mergers and Acquisitions
    • 5.2.5 Regulatory and Legal
  • 5.3 Market Share Analysis
  • 5.4 Company Profiles
    • 5.4.1 ANTARES VISION S.p.A
      • 5.4.1.1 Company Overview
      • 5.4.1.2 ANTARES VISION S.p.A in Global Pharmaceutical Quality Management Software Market
      • 5.4.1.3 Product Portfolio
      • 5.4.1.4 Financials
      • 5.4.1.5 Recent Developments
      • 5.4.1.6 SWOT Analysis
    • 5.4.2 AssurX, Inc.
      • 5.4.2.1 Company Overview
      • 5.4.2.2 Role of AssurX, Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.2.3 Product Portfolio
      • 5.4.2.4 SWOT Analysis
    • 5.4.3 AXSource
      • 5.4.3.1 Company Overview
      • 5.4.3.2 Role of AXSource in Global Pharmaceutical Quality Management Software Market
      • 5.4.3.3 Product Portfolio
      • 5.4.3.4 Recent Developments
      • 5.4.3.5 SWOT Analysis
    • 5.4.4 CLARIVATE PLC.
      • 5.4.4.1 Company Overview
      • 5.4.4.2 Role of CLARIVATE PLC. in Global Pharmaceutical Quality Management Software Market
      • 5.4.4.3 Product Portfolio
      • 5.4.4.4 Financials
      • 5.4.4.5 Recent Developments
      • 5.4.4.6 SWOT Analysis
    • 5.4.5 ComplianceQuest
      • 5.4.5.1 Company Overview
      • 5.4.5.2 Role of ComplianceQuest in Global Pharmaceutical Quality Management Software Market
      • 5.4.5.3 Product Portfolio
      • 5.4.5.4 Recent Developments
      • 5.4.5.5 SWOT Analysis
    • 5.4.6 Dassault Systemes
      • 5.4.6.1 Company Overview
      • 5.4.6.2 Role of Dassault Systemes in Global Pharmaceutical Quality Management Software Market
      • 5.4.6.3 Product Portfolio
      • 5.4.6.4 Financials
      • 5.4.6.5 SWOT Analysis
    • 5.4.7 EtQ Management Consultants, Inc.
      • 5.4.7.1 Company Overview
      • 5.4.7.2 Role of EtQ Management Consultants, Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.7.3 Product Portfolio
      • 5.4.7.4 Recent Developments
      • 5.4.7.5 SWOT Analysis
    • 5.4.8 Honeywell International Inc.
      • 5.4.8.1 Company Overview
      • 5.4.8.2 Role of Honeywell International Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.8.3 Product Portfolio
      • 5.4.8.4 Financials
      • 5.4.8.5 Recent Developments
      • 5.4.8.6 SWOT Analysis
    • 5.4.9 Ideagen Plc.
      • 5.4.9.1 Company Overview
      • 5.4.9.2 Role of Ideagen Plc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.9.3 Product Portfolio
      • 5.4.9.4 Financials
      • 5.4.9.5 Recent Developments
      • 5.4.9.6 SWOT Analysis
    • 5.4.10 IQVIA HOLDINGS INC.
      • 5.4.10.1 Company Overview
      • 5.4.10.2 Role of IQVIA HOLDINGS INC. in Global Pharmaceutical Quality Management Software Market
      • 5.4.10.3 Product Portfolio
      • 5.4.10.4 Financials
      • 5.4.10.5 SWOT Analysis
    • 5.4.11 LogicGate, Inc
      • 5.4.11.1 Company Overview
      • 5.4.11.2 Role of LogicGate, Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.11.3 Product Portfolio
      • 5.4.11.4 Recent Developments
      • 5.4.11.5 SWOT Analysis
    • 5.4.12 MasterControl
      • 5.4.12.1 Company Overview
      • 5.4.12.2 Role of MasterControl in Global Pharmaceutical Quality Management Software Market
      • 5.4.12.3 Product Portfolio
      • 5.4.12.4 Recent Developments
      • 5.4.12.5 SWOT Analysis
    • 5.4.13 PTC Inc.
      • 5.4.13.1 Company Overview
      • 5.4.13.2 Role of PTC Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.13.3 Product Portfolio
      • 5.4.13.4 Financials
      • 5.4.13.5 Recent Developments
      • 5.4.13.6 SWOT Analysis
    • 5.4.14 Sarjen Systems Pvt. Ltd.
      • 5.4.14.1 Company Overview
      • 5.4.14.2 Role of Sarjen Systems Pvt. Ltd. in the Global Pharmaceutical Quality Management Software Market
      • 5.4.14.3 Product Portfolio
      • 5.4.14.4 SWOT Analysis
    • 5.4.15 Qualio
      • 5.4.15.1 Company Overview
      • 5.4.15.2 Role of Qualio in Global Pharmaceutical Quality Management Software Market
      • 5.4.15.3 Product Portfolio
      • 5.4.15.4 Recent Developments
      • 5.4.15.5 SWOT Analysis
    • 5.4.16 Veeva Systems Inc.
      • 5.4.16.1 Company Overview
      • 5.4.16.2 Role of Veeva Systems Inc. in Global Pharmaceutical Quality Management Software Market
      • 5.4.16.3 Product Portfolio
      • 5.4.16.4 Financials
      • 5.4.16.5 SWOT Analysis
  • 5.5 Company Snapshots
    • 5.5.1 Key IT/Conglomerate Companies
      • 5.4.1.2 IBM
        • 5.5.1.1.1 Company Overview
        • 5.5.1.1.2 Role of IBM in Global Pharmaceutical Quality Management Software Market
      • 5.5.1.2 Oracle
        • 5.5.1.2.1 Company Overview
        • 5.5.1.2.2 Role of Oracle in Global Pharmaceutical Quality Management Software Market
      • 5.5.1.3 SAP SE
        • 5.5.1.3.1 Company Overview
        • 5.5.1.3.2 Role of SAP SE in Global Pharmaceutical Quality Management Software Market
      • 5.5.1.4 Siemens AG
        • 5.5.1.4.1 Company Overview
        • 5.5.1.4.2 Role Siemens AG in Global Pharmaceutical Quality Management Software Market
      • 5.5.1.5 Tata Elxsi
        • 5.5.1.5.1 Company Overview
        • 5.5.1.5.2 Role of Tata Elxsi in Global Pharmaceutical Quality Management Software Market

6 Research Methodology

  • 6.1 Data Sourcing
    • 6.1.1 Primary Data Sourcing
    • 6.1.2 Secondary Data Sourcing
  • 6.2 Data Triangulation
  • 6.3 Market Estimation
    • 6.3.1 Factors for Data Prediction and Modeling
  • 6.4 Assumptions and Limitations

List of Figures

  • Figure 1: Global Pharmaceutical Quality Management Software Market, Dynamics Impact Analysis
  • Figure 2: Global Pharmaceutical Quality Management Software Market (by Region), $Million, 2020 and 2030
  • Figure 3: Global Pharmaceutical Quality Management Software Market Incremental Opportunity, $Million, 2020-2030
  • Figure 4: Global Pharmaceutical Quality Management Software Market Segmentation
  • Figure 5: Global Pharmaceutical Quality Management Software Market, Realistic Growth Scenario, $Million, 2020-2030
  • Figure 6: Global Pharmaceutical Quality Management Software Market, Optimistic Growth Scenario, $Million, 2020-2030
  • Figure 7: Global Pharmaceutical Quality Management Software Market, Pessimistic/Conservative Growth Scenario, $Million, 2020-2030
  • Figure 8: Global Pharmaceutical Quality Management Software Market, Key Trends
  • Figure 9: Global Pharmaceutical Quality Management Software Market, Value Chain Analysis
  • Figure 10: Readiness Index: Pharmaceutical Quality Management Software
  • Figure 11: Pharmaceutical Quality Management Software Market: Technology Adoption Matrix
  • Figure 12: Global Pharmaceutical Quality Management Software Market, Patent Analysis (by Year), January 2014-June 2021
  • Figure 13: Global Pharmaceutical Quality Management Software Market, Patent Analysis (by Country), January 2014-June 2021
  • Figure 14: Global Pharmaceutical Quality Management Software Market, COVID-19 Impact Analysis (With COVID-19 Vs. Without COVID-19)
  • Figure 15: COVID-19 Impact Analysis on Global Pharmaceutical Quality Management Software Market Adoption
  • Figure 16: Cloud-Enabled Pharmaceutical Quality Management Software Ecosystem
  • Figure 17: Global Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
  • Figure 18: Most Common Business Models for Pharmaceutical Quality Management Software
  • Figure 19: Global Pharmaceutical Quality Management Software Market (by Application)
  • Figure 20: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by Application), $Million, 2020-2030
  • Figure 21: Global Pharmaceutical Quality Management Software Market Growth-Share Matrix (by Application), 2020-2030
  • Figure 22: Process of Initiating and Implementing a CAPA
  • Figure 23: Global Pharmaceutical Quality Management Software Market (CAPA Management), $Million, 2020-2030
  • Figure 24: Global Pharmaceutical Quality Management Software Market (Audit Management), $Million, 2020-2030
  • Figure 25: Workflow of a Typical Pharmaceutical Document Management Software System
  • Figure 26: Global Pharmaceutical Quality Management Software Market (Document Management), $Million, 2020-2030
  • Figure 27: Changes Reported Through Change Management in Pharmaceutical Industry
  • Figure 28: Global Pharmaceutical Quality Management Software Market (Change Management), $Million, 2020-2030
  • Figure 29: Global Pharmaceutical Quality Management Software Market (Training Management), $Million, 2020-2030
  • Figure 30: Global Pharmaceutical Quality Management Software Market (Risk Management), $Million, 2020-2030
  • Figure 31: Workflow in a Pharmaceutical Company on Receiving a Complaint
  • Figure 32: Global Pharmaceutical Quality Management Software Market (Complaints Management), $Million, 2020-2030
  • Figure 33: Global Pharmaceutical Quality Management Software Market (Regulatory and Compliance Management), $Million, 2020-2030
  • Figure 34: Workflow on Non-Conformance Handling
  • Figure 35: Global Pharmaceutical Quality Management Software Market (Non-Conformance Handling), $Million, 2020-2030
  • Figure 36: Global Pharmaceutical Quality Management Software Market (Supplier Quality Management), $Million, 2020-2030
  • Figure 37: Global Pharmaceutical Quality Management Software Market (Inspection Management), $Million, 2020-2030
  • Figure 38: Global Pharmaceutical Quality Management Software Market (Equipment Management), $Million, 2020-2030
  • Figure 39: Global Pharmaceutical Quality Management Software Market (Others), $Million, 2020-2030
  • Figure 40: Global Pharmaceutical Quality Management Software Market (by End User)
  • Figure 41: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by End User), $Million, 2020-2030
  • Figure 42: Global Pharmaceutical Quality Management Software Market (Pharmaceutical, Lifesciences, and Biotechnology Companies), $Million, 2020-2030
  • Figure 43: Global Pharmaceutical Quality Management Software Market (Contract Research Organizations), $Million, 2020-2030
  • Figure 44: Global Pharmaceutical Quality Management Software Market (Others), $Million, 2020-2030
  • Figure 45: Global Pharmaceutical Quality Management Software Market (by Deployment Model)
  • Figure 46: Global Pharmaceutical Quality Management Software Market Incremental Opportunity (by Deployment Model), $Million, 2020-2030
  • Figure 47: Global Pharmaceutical Quality Management Software Market Growth-Share Matrix (by Deployment Model), 2020-2030
  • Figure 48: Global Pharmaceutical Quality Management Software Market (On-Cloud), $Million, 2020-2030
  • Figure 49: Global Pharmaceutical Quality Management Software Market (Web-Based), $Million, 2020-2030
  • Figure 50: Global Pharmaceutical Quality Management Software Market (On-Premises), $Million, 2020-2030
  • Figure 51: Global Pharmaceutical Quality Management Software Market Share (by Region), 2020-2030
  • Figure 52: North America Pharmaceutical Quality Management Software Market Incremental Revenue Opportunity (by Country), $Million, 2020-2030
  • Figure 53: North America Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 54: North America Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
  • Figure 55: North America Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
  • Figure 56: North America Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
  • Figure 57: U.S. Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 58: Canada Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 59: Europe Pharmaceutical Quality Management Software Market Incremental Opportunity (by Country), $Million, 2020-2030
  • Figure 60: Europe Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 61: Europe Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
  • Figure 62: Europe Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
  • Figure 63: Europe Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
  • Figure 64: Germany Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 65: U.K. Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 66: France Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 67: Italy Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 68: Spain Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 69: Rest-of-Europe Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 70: Asia-Pacific Pharmaceutical Quality Management Software Market Incremental Revenue Opportunity (by Country), $Million, 2020-2030
  • Figure 71: Asia-Pacific Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 72: Asia-Pacific Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
  • Figure 73: Asia-Pacific Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
  • Figure 74: Asia-Pacific Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
  • Figure 75: Japan Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 76: China Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 77: South Korea Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 78: India Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 79: Australia and New Zealand Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 80: Rest-of-Asia-Pacific Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 81: Rest-of-the-World Pharmaceutical Quality Management Software Market Incremental Opportunity (by Country), $Million, 2020-2030
  • Figure 82: Rest-of-the-World Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 83: Rest-of-the-World Pharmaceutical Quality Management Software Market (by End User), $Million, 2020-2030
  • Figure 84: Rest-of-the-World Pharmaceutical Quality Management Software Market (by Deployment Model), $Million, 2020-2030
  • Figure 85: Rest-of-the-World Pharmaceutical Quality Management Software Market (by Country), $Million, 2020 and 2030
  • Figure 86: Brazil Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 87: Mexico Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 88: Rest of Rest-of-the-World Pharmaceutical Quality Management Software Market, $Million, 2020-2030
  • Figure 89: Global Pharmaceutical Quality Management Software Market, Company Benchmarking
  • Figure 90: Share of Key Developments and Strategies in the Global Pharmaceutical Quality Management Software Market (by Category), January 2018-August 2021
  • Figure 91: Global Pharmaceutical Quality Management Software Market, Key Developments, January 2018-August 2021
  • Figure 92: Global Pharmaceutical Quality Management Software Market, Partnerships, Alliances, and Business Expansions (by Company), January 2018-August 2021
  • Figure 93: Global Pharmaceutical Quality Management Software Market, New Offerings (by Company), January 2018-August 2021
  • Figure 94: Global Pharmaceutical Quality Management Software Market, Funding Activities (by Company), January 2018-August 2021
  • Figure 95: Global Pharmaceutical Quality Management Software Market, Mergers and Acquisitions (by Company), January 2018-August 2021
  • Figure 96: Global Pharmaceutical Quality Management Software Market, Company Revenue Share Analysis, 2020
  • Figure 97: ANTARES VISION S.p.A: Overall Financials, 2018-2020
  • Figure 98: CLARIVATE PLC.: Overall Financials, 2018-2020
  • Figure 99: Dassault Systemes: Overall Financials, 2018-2020
  • Figure 100: Dassault Systemes: R&D Expenditure, $Million, 2018-2020
  • Figure 101: Honeywell International Inc.: Overall Financials, 2018-2020
  • Figure 102: Honeywell International Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 103: Ideagen Plc.: Overall Financials, 2018-2020
  • Figure 104: Ideagen Plc.: R&D Expenditure, $Million, 2018-2020
  • Figure 105: IQVIA HOLDINGS INC.: Overall Financials, 2018-2020
  • Figure 106: IQVIA HOLDINGS INC.: R&D Expenditure, $Million, 2018-2020
  • Figure 107: PTC Inc.: Overall Financials, 2018-2020
  • Figure 108: PTC Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 109: Veeva Systems Inc.: Overall Financials, 2019-2021
  • Figure 110: Veeva Systems Inc.: R&D Expenditure
  • Figure 111: Global Pharmaceutical Quality Management Software Market, Research Methodology
  • Figure 112: Data Triangulation
  • Figure 113: Assumptions and Limitations

List of Tables

  • Table 1: Key Barriers and Possible Solutions to Entering the Global Pharmaceutical Quality Management Software Market
  • Table 2: Global Pharmaceutical Quality Management Software Market Quarterly Key Developments Analysis, January 2018-August 2021
  • Table 3: Global Pharmaceutical Quality Management Software Market, Exclusion Criteria
  • Table 4: Global Pharmaceutical Quality Management Software Market, Key Trends
  • Table 5: Global Pharmaceutical Quality Management Software Market, Cost-Benefit Analysis, $Thousands
  • Table 6: Case Study: Alphazyme and Qualio
  • Table 7: Case Study: AL Andalous and AmpleLogic
  • Table 8: Annual R&D Expenditure of Pharmaceutical Companies
  • Table 9: Global Pharmaceutical Quality Management Software Market, Opportunity Impact Analysis
  • Table 10: North America Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
  • Table 11: North America Pharmaceutical Quality Management Software Market Regulations
  • Table 12: Europe Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
  • Table 13: Europe Pharmaceutical Quality Management Software Market Regulations
  • Table 14: Asia-Pacific Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
  • Table 15: Asia-Pacific Pharmaceutical Quality Management Software Market Regulations
  • Table 16: Rest-of-the-World Pharmaceutical Quality Management Software Market Dynamics Impact Analysis
  • Table 17: Rest-of-the-World Pharmaceutical Quality Management Software Market Regulations
  • Table 18: ANTARES VISION S.p.A: Product Portfolio
  • Table 19: AssurX, Inc.: Product Portfolio
  • Table 20: AXSource: Product Portfolio
  • Table 21: CLARIVATE PLC.: Product Portfolio
  • Table 22: ComplianceQuest: Product Portfolio
  • Table 23: Dassault Systemes: Product Portfolio
  • Table 24: EtQ Management Consultants.: Product Portfolio
  • Table 25: Honeywell International Inc.: Product Portfolio
  • Table 26: Ideagen Plc.: Product Portfolio
  • Table 27: IQVIA HOLDINGS INC.: Product Portfolio
  • Table 28: LogicGate, Inc.: Product Portfolio
  • Table 29: MasterControl: Product Portfolio
  • Table 30: PTC Inc.: Product Portfolio
  • Table 31: Sarjen Systems Pvt. Ltd.: Product Portfolio
  • Table 32: Qualio: Product
  • Table 33: Veeva Systems Inc.: Product Portfolio